![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 25/08 | |
A61K 31/165 | |||
A61P 9/06 |
(11) | Number of the document | 2345455 |
(13) | Kind of document | T |
(96) | European patent application number | 11002768.7 |
Date of filing the European patent application | 2007-06-29 | |
(97) | Date of publication of the European application | 2011-07-20 |
(45) | Date of publication and mention of the grant of the patent | 2016-03-16 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
06013655 | 2006-06-30 | EP | |
06021469 | 2006-10-12 | EP | |
06021470 | 2006-10-12 | EP | |
06024241 | 2006-11-22 | EP |
(72) |
Beyreuther, Bettina, DE
Heers, Cara, DE
Stöhr, Thomas, BE
|
(73) |
UCB Pharma GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
(54) | Lacosamide for the treatment of hyperexcitability disorders associated with sodium channel dysfunction |
Lacosamide for the treatment of hyperexcitability disorders associated with sodium channel dysfunction |